MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Next-generation sequencing of plasma-associated extracellular vesicle miRNAs as potential biomarkers for Parkinson’s disease and its prodromal stage

    L. Li, L. Liu (Shanghai, China)

    Objective: This study aimed to identify subsets of plasma EV-associated miRNAs with diagnostic potential for PD and iRBD, the prodromal stage of PD. Background: Parkinson’s…
  • MDS Virtual Congress 2021

    Metabolic alterations in a Drosophila model of Parkinson’s disease

    C. Solana-Manrique, F J. Sanz, I. Torregrosa, N. Paricio (Burjassot, Spain)

    Objective: Identification of metabolic alterations that could be contributing to Parkinson’s disease (PD) physiopathology and become new biomarkers or therapeutic targets for the disease. Background:…
  • MDS Virtual Congress 2021

    Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE

    G. Coughlan, P. Mclaughlin, K. Sunderland, M. Borrie, C. Fischer, A. Frank, M. Freedman, S. Kumar, S. Pasternak, B. Pollock, T. Rajji, D. Seitz, D. Tang-Wai, C. Tartaglia, J. Dewar, D. Kwan, B. Tan, D. Grimes, M. Jog, T. Lang, C. Marras, T. Steeves, D. Bulman, A. Dilliott, M. Ghani, R. Hegele, J. Robinson, E. Rogaeva, S. Farhan, R. Bartha, N. Nanayakkara, J. Ramirez, C. Scott, S. Symons, C. Berezuk, M. Holmes, S. Adamo, M. Ozzoude, A. Theyers, S. Arnott, D. Beaton, W. Lou, S. Sujanthan, B. Levine, J. Orange, A. Peltsch, A. Roberts, A. Troyer, M. Binns, S. Black, S. Strother, M. Moscovitch, C. Grady, M. Masellis (Toronto, Canada)

    Objective: As part of the Ontario Neurodegenerative Disease Research Initiative, we investigated group differences in functional connectivity within two distinct memory networks: posterior medial network…
  • MDS Virtual Congress 2021

    Striatal dopaminergic loss in early clinically unilateral Parkinson’s disease: a systematic review

    N. Heng, N. Malek, M. Lawton, K. Grosset, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

    Objective: To quantify the extent of dopaminergic loss in early clinically unilateral PD from studies using presynaptic dopamine imaging with either single photon emission computed tomography…
  • MDS Virtual Congress 2021

    Characteristics of the amyloid beta networks in Parkinson’s disease patients: a PPMI study

    A. Mihascu, M. Valli, M. Diez-Cirarda, Y. Koshimori, J. Kim, A. Strafella (Toronto, Canada)

    Objective: The impact that amyloid beta (Aβ) accumulation in the brain has on the progression of Parkinson’s disease (PD) pathology is complex and poorly understood…
  • MDS Virtual Congress 2021

    The Influence of Affective Priming on the Speech Production Network in Parkinson’s Disease

    J. Schill, P. Sörös, K. Simonyan, C. Thiel, K. Witt (Oldenburg, Germany)

    Objective: Examine Parkinson’s disease (PD) related changes in the speech production network (SPN) and its reaction to emotional distraction. Background: PD can cause speech alterations…
  • MDS Virtual Congress 2021

    Neuroanatomical signatures of genetic risk for Parkinson’s Disease in healthy adults

    S. Waters, J. Kim, C. Watson, B. Jacobs, I. Foote, S. Dey, C. Blauwendraat, A. Noyce, C. Marshall (London, United Kingdom)

    Objective: To determine whether there is a relationship between genetic risk for Parkinson’s disease (PD) and brain structure in healthy adults. Background: PD pathology begins…
  • MDS Virtual Congress 2021

    Inter-Electrode Distance Influences the Spectral Power of Subthalamic Bipolar Local Field Potentials Recordings in Parkinson’s Disease

    A. Averna, S. Marceglia, M. Arlotti, M. Locatelli, P. Rampini, A. Priori, T. Bocci (Milan, Italy)

    Objective: This study aimed to evaluate spectral dissimilarities and their correlations with clinical symptoms of intra-operative local field potentials (LFP) acquired from wide- and close-spaced…
  • MDS Virtual Congress 2021

    Early Adapter: Study Protocol for the Multi-Center Post-Market Study of Adaptive Deep Brain Stimulation (aDBS) in Japan

    G. Oyama, A. Nakajima, H. Kamo, M. Nuermaimaiti, A. Bovet, J. Eubanks, H. Iwamuro, A. Umemura, N. Hattori, Y. Shimo (Tokyo, Japan)

    Objective: To assess the procedures for introducing two adaptive deep brain stimulation (aDBS) modes (single and dual threshold) in Parkinson’s disease patients (PD) in a…
  • MDS Virtual Congress 2021

    Autonomic Symptoms as Predictors of Quality of Life in Parkinson’s Disease: A 5-year follow up study

    A. Bougea, S. Pantinaki, A. Antonoglou, P. Giannaki, F. Efthymiopoulou (Athens, Greece)

    Objective: The aim of this study was to investigate whether the autonomic symptoms could predict the quality of life of patients with PD. Background: Parkinson's…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley